Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Endo to pay $830M to settle pelvic mesh lawsuits
Yahoo/AP
Wednesday, April 30, 2014 - 7:05pm
tags:
pelvic mesh, vaginal mesh, devices, Endo Health Solutions
Would Merck Be the Best Buyer for AstraZeneca?
Motley Fool
Wednesday, April 30, 2014 - 6:46pm
tags:
M&A, AstraZeneca, Merck, Pfizer, diabetes
With Big Pharma mergers in the works, whose SG&A costs look ripe for cutting?
Fierce Pharma Marketing
Wednesday, April 30, 2014 - 1:10pm
tags:
layoffs, M&A, Novartis, GSK, Pfizer, AstraZeneca
WellPoint says hepatitis C drugs Q1 cost was $50 mln
Yahoo/Reuters
Wednesday, April 30, 2014 - 1:08pm
tags:
hepatitis C, drug costs, Wellpoint, Sovaldi, Gilead Sciences
No Longer King Of The North, Pfizer Looks To Recapture Crown
Forbes
Wednesday, April 30, 2014 - 1:03pm
tags:
Pfizer, M&A
Members of Parliament to grill Pfizer chiefs over bid for AstraZeneca
Independent, UK
Wednesday, April 30, 2014 - 1:01pm
tags:
M&A, UK, Pfizer, AstraZeneca
Synergy Pharmaceuticals' plecanatide shows positive results in Phase 2B study
Yahoo/Fly on the Wall
Wednesday, April 30, 2014 - 12:58pm
tags:
Synergy Pharmaceuticals, plecanatide, IBS-C
Surveying the therapeutic areas pharma participates in on facebook, YouTube and Pinterest
Cutting Edge Info
Wednesday, April 30, 2014 - 12:56pm
tags:
social media
New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala
Seeking Alpha
Wednesday, April 30, 2014 - 12:50pm
tags:
melanoma, Bristol-Myers Squibb, Roche, Merck, Amgen
Regeneron chief outranks every other biopharma CEO with $36M in 2013 pay
Fierce Pharma
Wednesday, April 30, 2014 - 12:39pm
tags:
Regeneron, executive pay
6 Drugs That Could Move the Pharma Market
Wall St Cheat Sheet
Wednesday, April 30, 2014 - 12:37pm
tags:
Gilead Sciences, Teva Pharmaceuticals, Copaxone, Idelalisib, Bristol-Myers Squibb, nivolumab, Cyramza, Eli Lilly, Pfizer, palbociclib, Sovaldi
Stymied by Meda, deal-hungry Mylan could jump on Stada or Mallinckrodt
Fierce Pharma
Wednesday, April 30, 2014 - 12:31pm
tags:
Stada, Meda, Mylan, Mallinckrodt, M&A
GSK says staying on sidelines in Astra, Pfizer fight
Yahoo/Reuters
Wednesday, April 30, 2014 - 10:39am
tags:
GSK, M&A, Pfizer, AstraZeneca
Pfizer's post-megamerger cost-cutting record? 51,500 jobs in 7 years
Fierce Pharma
Wednesday, April 30, 2014 - 10:33am
tags:
Pfizer, layoffs, M&A, restructuring, Wyeth, Merck, Schering Plough
Sources: Bayer offers animal health biz, cash for Merck's OTC unit
Fierce Pharma
Wednesday, April 30, 2014 - 10:32am
tags:
Bayer, OTC, Merck, animal health, M&A, consumer health
Drugs That Will Help Johnson & Johnson Grow By 5% In 2014
Forbes
Wednesday, April 30, 2014 - 10:28am
tags:
JNJ, Remicade, Olysio, Velcade, Zytiga
Teva's abuse-resistant painkiller succeeds in study
Yahoo/Reuters
Wednesday, April 30, 2014 - 10:25am
tags:
painkillers, Teva Pharmaceuticals, CEP-33237, hydrocodone, abuse-resistant painkillers
Shire says new dry-eye drug fails to meet trial goal
Yahoo/Reuters
Wednesday, April 30, 2014 - 10:23am
tags:
Shire, dry eye disease, Lifitegrast
FDA weighs risks of approving Singulair as over-the-counter allergy medication
Yahoo/AP
Wednesday, April 30, 2014 - 10:22am
tags:
Singulair, FDA, OTC, Merck
Incorrect biopsy results cloud Nymox Pharma prostate cancer study
Yahoo/Reuters
Wednesday, April 30, 2014 - 10:21am
tags:
Nymox, prostate cancer, NX-1207

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.